Salzburg, Austria

Michael Trenker

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2011.



Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Trenker: Innovator in Oxidized Phospholipids

Introduction

Michael Trenker is a notable inventor based in Salzburg, Austria. He has made significant contributions to the field of biochemistry, particularly through his work on oxidized phospholipids. His innovative approach has led to the development of a unique patent that showcases his expertise and creativity.

Latest Patents

Michael Trenker holds a patent related to oxidized phospholipids. The invention pertains to oxidized phospholipids characterized by specific general formulas, which include various components such as A, B, and R, with R being selected from a group of chemical structures. This patent represents a significant advancement in the understanding and application of phospholipids in various scientific fields. He has 1 patent to his name.

Career Highlights

Throughout his career, Trenker has worked with esteemed institutions, including Technische Universität Graz. His experience in these environments has allowed him to refine his skills and contribute to groundbreaking research in his field. His work has been recognized for its potential impact on biochemistry and related disciplines.

Collaborations

Michael Trenker has collaborated with notable professionals, including Albin Hermetter. These partnerships have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Michael Trenker's contributions to the field of oxidized phospholipids highlight his role as an influential inventor. His patent and collaborations reflect his commitment to advancing scientific knowledge and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…